Crossmark

pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation

Published Online: 2019-01-31

Authors

Sonnenblick, Amir https://orcid.org/0000-0003-1954-4633
Venet, David

Brohée, Sylvain

Pondé, Noam

Sotiriou, Christos
Funding

Funding for this research was provided by:

Israel Cancer Research Fund (16-116-CRCDA)

Breast Cancer Research Foundation
License Information

Text and Data Mining valid from 2019-01-31

Version of Record valid from 2019-01-31
More Information

Article History

Received: 27 May 2018

Accepted: 8 January 2019

First Online: 31 January 2019

Competing interests

: The authors declare no competing interests.

Document is current